Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...
RMAT designation is based on promising Phase 2 clinical data demonstrating NG01’s potential to reduce disability and ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.
Hosted on MSN
Breakthrough multiple sclerosis therapy by UCSF doctor transforms treatment for millions
Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...
Scientists have demonstrated in mouse studies that specially designed probiotics can reduce brain inflammation associated with diseases like multiple sclerosis. The study points to new potential ...
A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...
Share on Pinterest Stem cell therapy could help halt the progression of cognitive impairment in multiple sclerosis. Image credit: TEK IMAGE/SCIENCE PHOTO LIBRARY/Getty Images. About 2.8 million people ...
A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results